← Open Payments lookup

DAVID ABIVA: Open Payments

NPI 1295858215 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,293 in 28 payments from 13 companies in 2025. Trend: 2023 $1,364 · 2024 $1,747 · 2025 $2,293

Food & beverage: $2,293
CompanyPaymentsAmount
Amgen Inc.3$401
AstraZeneca Pharmaceuticals LP3$359
Novo Nordisk Inc8$225
Madrigal Pharmaceuticals3$183
Edwards Lifesciences Corporation1$169
Axsome Therapeutics, Inc.2$147
Otsuka America Pharmaceutical, Inc.1$143
Boehringer Ingelheim Pharmaceuticals, Inc.2$141
Phathom Pharmaceuticals, Inc.1$127
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$125

Products named: REPATHA, AIRSUPRA, REZDIFFRA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Ozempic, Symbravo, JARDIANCE, VOQUEZNA.

Industry payments across CA — which companies pay providers there.